Breast cancer patients more satisfied when specialists share care management
December 15, 2011 By Katherine Kahn in Cancer
Patients with breast cancer report greater satisfaction with care when their cancer doctor co-manages their care with other specialists. However, some specialists are more likely than others to share decision-making with other physicians, finds a new study in Health Services Research.
Breast cancer is typically a condition that is managed by multiple specialists. Often a surgeon is involved as well as a medical oncologist, radiologist and primary care physician, said Katherine Kahn, M.D., of the David Geffen School of Medicine at UCLA and senior author of the study.
For certain tasks associated with breast cancer diagnosis and treatment, co-managementwhere two or more physicians actively consult with one anothermight be the best approach. However, the extent to which specialists use co-management in breast cancer care is unknown.
Researchers surveyed 347 breast cancer specialists, including medical oncologists, radiation oncologists and surgeons, about their usual practice style for 10 clinical tasks associated with breast cancer care. The specialists answered questions about whether they manage common breast cancer treatment tasks independently, co-manage tasks with other physicians or refer patients to other providers. Radiation oncologists reported co-managing more tasks, followed by surgeons and medical oncologists.
To examine patient outcomes, the researchers identified satisfaction ratings from 411 patients matched to a surveyed medical oncologist. Patients gave higher ratings to medical oncologists who actively co-managed decision makingrather than simply referring patients to another specialistin four different areas: choosing type of breast surgery, decisions about radiation, treatment of lymphedema (limb swelling after breast surgery) and treatment of depression.
Patients wanted to have one physician that they identified as coordinating their careas co-managing, not just referring them outand connected to all of the information that was relevant to the decision making for the patient, Kahn said.
Certain factors were associated with the co-management of patients. Physicians in HMOs who have greater access to other clinicians than physicians in solo practice were more likely to co-manage patients. Physicians who received financial incentives to expand their own services or who encountered barriers to referral because of provider network restrictions were less likely to collaborate with other doctors about patient care.
Perhaps one way of going forward is to look at this from the patients perspective, said Richard Wender, M.D., chairman of the department of family medicine at Jefferson Medical College and past president of the American Cancer Society.
What patients want is the sense that they are being cared for in a continuous way, Wender added. We in the cancer care community increasingly recognize that we have a fundamental professional and ethical responsibility to take a patient-centered approach to cancer care. That means that the same kinds of interdisciplinary team thinking that has been applied to some other chronic illnesses must consistently be applied to cancer care.
More information: Rose, D. E., D. M. Tisnado, M. L. Tao, J. L. Malin, J. L. Adams, P. A. Ganz, and K. L. Kahn. (2011). Prevalence, Predictors, and Patient Outcomes Associated with Physician Co-management: Findings from the Los Angeles Womens Health Study. Health Services Research, doi: 10.1111/j.1475-6773.2011.01359.x
Provided by
Health Behavior News Service
-
Few breast cancer surgeons follow quality of care standards, study finds
Jan 05, 2010 |
not rated yet |
0
-
Breast cancer patients lack adequate fertility preservation advice
Nov 07, 2011 |
not rated yet |
0
-
Physician characteristics are associated with quality of cancer care
Jan 29, 2008 |
not rated yet |
0
-
Few physicians refer patients to cancer clinical trials
Feb 12, 2011 |
not rated yet |
0
-
Referral decisions differ between primary care physicians and specialists
Sep 19, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
13 hours ago
-
Popping/Cracked sternum.
18 hours ago
-
Which Mental Illness Encompasses This Problem?
18 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
May 25, 2012 |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
May 25, 2012 |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
May 25, 2012 |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
May 25, 2012 |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
May 25, 2012 |
not rated yet |
1
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.